Source: Annual Congress 2009 - Drug effects in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Wollin, M. Pieper (Biberach, Germany). Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Eur Respir J 2009; 34: Suppl. 53, 2004

Member's Comments

No comment yet.

Related content which might interest you: The antiinflammatory and antioxidant effect of tiotropium bromide in subacute cigarette exposure mouse model Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Tiotropium inhibits pulmonary inflammation in a subchronic cigarette smoke mouse model of COPD Source: Annual Congress 2010 - Bronchodilators in airways disease Year: 2010 A comparison of anti-inflammatory compounds in a steroid-insensitive mouse tobacco smoke model Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases Year: 2012 Tiotropium reduces established pulmonary inflammation in a 12 weeks cigarette smoke mouse model of COPD Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011 Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Adjuvant and anti-inflammatory properties of cigarette smoke in murine models of allergic airways inflammation Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008 Aclidinium inhibits cigarette smoke-induced lung fibroblast-to-myofibroblast transition Source: Eur Respir J 2013; 41: 1264-1274 Year: 2013 Evaluation of antiinflammatory and antioxidant effect of mepenzolate in subacute cigarette exposure mouse model Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Cryptotanshinone attenuates airway Inflammation induced by cigarette smoke in mice Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Tiotropium inhalation prevents acute cigarette smoke-induced airway inflammation in mice Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Lung function response to budesonide and ipratropium bromide in COPD patients who continue smoking Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002 Neu-164, a novel antioxidant and anti-inflammatory compound, reduces cigarette smoke-induced lung inflammation Source: Annual Congress 2008 - COPD Year: 2008 Comparative anti-oxidant effects of carbocysteine and fluticasone propionate in cigarette smoke stimulated airway epithelial cells Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Sildenafil in a cigarette smoke-induced model of COPD in the guinea-pig Source: Eur Respir J 2015; 46: 346-354 Year: 2015 Roflumilast inhibited emphysema development in mice exposed to cigarette smoke Source: Eur Respir J 2005; 26: Suppl. 49, 204s Year: 2005 Long-acting anticholinergic, aclidinium bromide (AB) significantly attenuates airway inflammation and hyper-responsiveness in an AF-induced murine model of asthma Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Carbocysteine reverses the effects of cigarette smoke and improves the effects of beclomethasone on the histone deacetylases in bronchial epithelial cells Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Potent anti-inflammatory effects of the highly selective iNOS inhibitor Byk402750 in a mouse model of cigarette smoke induced inflammation Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards Year: 2015 The protective effects of thymoquinone on lung damage developed by cigarette smoke Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017